申请人:Biomeasure, Inc., a Massachusetts corporation
公开号:US20030004342A1
公开(公告)日:2003-01-02
The present invention is directed to imidazolyl derivatives of formula (II), wherein the variables are defined in the specification, which are useful as prenyl transeferase inhibitors.
本发明涉及公式(II)的
咪唑基衍
生物,其中变量在规范中定义,可用作异
戊烯基转移酶
抑制剂。